54

Bharat Parenterals LtdBOM 541096 Stock Report

Last reporting period 31 Mar, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.012

Micro

Exchange

XBOM - Bombay Stock Exchange

541096.BO Stock Analysis

54

Avoid

Based on Eyestock quantitative analysis, 541096.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

6/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-84.0 %

Greatly overvalued

Market cap $B

0.012

Dividend yield

0.12 %

Shares outstanding

5.82 B

Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2018-03-21. The firm is focused on manufacturing of pharmaceutical formulations. The firm is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The firm offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other.

View Section: Eyestock Rating